 had the chance to sit down with Laura S. Wood, RN, MSN, OCN, renal cancer research coordinator at the Cleveland Clinic Taussig Cancer Center and one of the co-chairs of the School of Oncology Nursing, and discuss why she believes there are currently so many updates for various malignancies and where these updates are going.

So, we're seeing quite a few updates in the treatment options for a variety of malignancies. That really goes back to better understanding the pathobiology of various cancers and understanding the role of the immune system and being able to target, and or reactivate, the immune system and recognizing that that plays a role in all different malignancies. And so, the clinical trial data has really matured and enrollment in clinical trials has increased our ability to answer those questions and identify those treatment options that are appropriate and those that are not appropriate for FDA approval and treatment. 

Videos

There are a lot of treatment updates for various malignancies happening seemingly all at once. We had the chance to speak with Laura S. Wood, RN, MSN, OCN, for her take on why these updates are coming so rapidly.   

Keeping Track of the Most Recent Treatment Updates

 had the chance to sit down with Laura S. Wood, RN, MSN, OCN, renal cancer research coordinator at the Cleveland Clinic Taussig Cancer Center and one of the co-chairs of the School of Oncology Nursing, and discuss her presentation on GU malignancies highlighting one of the most important takeaways from the presentation.   

So as far as a presentation on GU malignancies and supportive care, I think it's important for nurses to take home the awareness that bone metastasis is a challenge, it does occur, and we need to make sure we assess and intervene early in order to minimize the negative impact it has on a patient. If we can control their systemic disease, the challenge is bones and brain are oftentimes more sanctuary sights and may not have the same benefit from therapy. So, we need to be astute in our assessment and awareness of these potential sites for metastasis and make sure we're intervening early because there are definitely advances in the options to treat those problems.

At the 3rd annual School of Oncology Nursing Laura S. Wood, RN, MSN, OCN, renal cancer research coordinator at the Cleveland Clinic Taussig Cancer Center and one of the co-chairs of the School of Oncology Nursing, presented on supportive care for GU malignancies and we had the chance to discuss the highlights with her.

Laura S. Wood, RN, MSN, OCN

Articles

Keeping Track of the Most Recent Treatment Updates

What Nurses Need to Know About GU Malignancies